BARBARA BURK: Open Payments
NPI 1588774210 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 18 payments from 13 companies in 2025. Trend: 2023 $525 · 2024 $301 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| ABBVIE INC. | 2 | $38 |
| Janssen Biotech, Inc. | 1 | $35 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Stemline Therapeutics Inc. | 1 | $29 |
| Caris MPI, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
Products named: ENHERTU, IBRANCE, FRUZAQLA, VENCLEXTA, ERLEADA, KEYTRUDA, Orserdu, MI CANCER SEEK.
Industry payments across GA — which companies pay providers there.
